|
26 Companies |
|
27 Products |
|
27 Products |
|
21 Mechanisms of Action |
|
1 Trial |
|
208 News |
|
| «12345» |
- |||| tacrolimus intravenous / Generic mfg.
Trial completion: A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy (clinicaltrials.gov) - Feb 22, 2014
P4, N=131, Completed, Sponsor: Astellas Pharma Inc
Active, not recruiting --> Completed
- | sildenafil / Generic mfg., papaverine / Generic mfg.
Trial completion: Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=111, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- New P3 trial: Pilot Study of the Treatment of Erectile Dysfunction (ED) With Extracorporeal Shockwave Therapy (ESWT) (clinicaltrials.gov) - Feb 19, 2014
P3, N=40, Terminated, Sponsor: Storz Medical AG
- ||||||| Trintellix (vortioxetine) / Lundbeck, Takeda
Trial completion: Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction (clinicaltrials.gov) - Jan 21, 2014
P3, N=447, Completed, Sponsor: Takeda
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial initiation date: Safety and Efficacy Associated With Treating Erectile Dysfunction Patients With Low Intensity Shockwaves by Renova (clinicaltrials.gov) - Dec 8, 2013
P=N/A, N=40, Recruiting, Sponsor: Initia
Active, not recruiting --> Completed Initiation date: May 2013 --> Oct 2013
- Enrollment open: Safety and Efficacy Associated With Treating Erectile Dysfunction Patients With Low Intensity Shockwaves by Renova (clinicaltrials.gov) - Dec 8, 2013
P=N/A, N=40, Recruiting, Sponsor: Initia
Initiation date: May 2013 --> Oct 2013 Not yet recruiting --> Recruiting
- ||| Clinical: LISW: Low Intensity Extracorporeal Shockwave Therapy for Patients With Erectile Dysfunction (clinicaltrials.gov) - Dec 5, 2013
P=N/A, N=58, Completed, Sponsor: Initia
- || Enrollment closed: Low Intensity Extracorporeal Shockwave Therapy (LI-ESWT) by 'Renova' for Patients With Erectile Dysfunction (clinicaltrials.gov) - Dec 3, 2013
P=N/A, N=60, Active, not recruiting, Sponsor: Initia
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Trial completion, Surgery: Sexual Dysfunction and Adaptation in Couples Affected by Prostate Cancer Surgery (clinicaltrials.gov) - Nov 21, 2013
P=N/A, N=50, Completed, Sponsor: University Health Network, Toronto
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||||||| Stendra (avanafil) / Vivus, Menarini, Endo
Trial completion: This Study is to Evaluate the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction. (clinicaltrials.gov) - Nov 17, 2013
P3, N=195, Completed, Sponsor: JW Pharmaceutical
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Estring (estradiol) / Pfizer
Trial completion: E-String: Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients (clinicaltrials.gov) - Nov 5, 2013
P2, N=76, Completed, Sponsor: University of California, San Francisco
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| Stendra (avanafil) / Vivus, Menarini, Endo
Enrollment closed: Study Evaluating the Effects of Avanafil on Semen Parameters (clinicaltrials.gov) - Oct 22, 2013
P4, N=220, Active, not recruiting, Sponsor: VIVUS, Inc.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||||| Zydena (udenafil) / Mezzion
New P2 trial: Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction (clinicaltrials.gov) - Oct 20, 2013
P2, N=950, Not yet recruiting, Sponsor: Takeda
- ||| Zydena (udenafil) / Mezzion
New P1 trial: Safety and Pharmacokinetic Profile of Udenafil in Healthy Mexican Adults (clinicaltrials.gov) - Oct 20, 2013
P1, N=83, Completed, Sponsor: Takeda
- |||||| tadalafil / Generic mfg.
Enrollment open: A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED) (clinicaltrials.gov) - Oct 8, 2013
P3, N=890, Recruiting, Sponsor: Eli Lilly and Company
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Clinical data, Adverse events: Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions (clinicaltrials.gov) - Sep 29, 2013
P=N/A, N=3000, Recruiting, Sponsor: Elliot Lander
- sildenafil / Generic mfg.
New P4 trial: Motor Response to Sildenafil in PD (clinicaltrials.gov) - Sep 9, 2013
P4, N=8, Completed, Sponsor: Bispebjerg Hospital
- sildenafil / Generic mfg.
Trial completion: Motor Response to Sildenafil in PD (clinicaltrials.gov) - Sep 9, 2013
P4, N=8, Completed, Sponsor: Bispebjerg Hospital
Not yet recruiting --> Recruiting Not yet recruiting --> Completed
- ||| tadalafil / Generic mfg.
Enrollment change: REACTT: A Study of Tadalafil After Radical Prostatectomy (clinicaltrials.gov) - Sep 9, 2013
P4, N=583, Completed, Sponsor: Eli Lilly and Company
Not yet recruiting --> Completed N=412 --> 583
- |||||||||| tadalafil / Generic mfg.
New P3 trial: A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED) (clinicaltrials.gov) - Sep 8, 2013
P3, N=890, Recruiting, Sponsor: Eli Lilly and Company
- | lidocaine topical / Generic mfg.
New P4 trial: Study to Compare the Efficacy of Cognitive-behavioral Couple Therapy and Lidocaine for Provoked Vestibulodynia (clinicaltrials.gov) - Sep 2, 2013
P4, N=224, Recruiting, Sponsor: Universit
- Vitaros (alprostadil + novel excipient) / Seelos Therap
Trial initiation date: Efficacy, Safety and Satisfaction of VITAROS (Transdermal Topical Alprostadil) in Men With Erectile Dysfunction (clinicaltrials.gov) - Aug 26, 2013
P4, N=0, Withdrawn, Sponsor: Lawson Health Research Institute
N=412 --> 583 Initiation date: Jan 2013 --> Dec 2013
- Vitaros (alprostadil + novel excipient) / Seelos Therap
Trial termination: Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction (clinicaltrials.gov) - Aug 4, 2013
P2, N=16, Terminated, Sponsor: Warner Chilcott
Initiation date: Jan 2013 --> Dec 2013 Suspended --> Terminated; Re-assessment of study
- Vitaros (alprostadil + novel excipient) / Seelos Therap
Enrollment change: Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction (clinicaltrials.gov) - Aug 4, 2013
P2, N=16, Terminated, Sponsor: Warner Chilcott
Suspended --> Terminated; Re-assessment of study N=30 --> 16
- ||||| Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
New P2 trial: A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation (clinicaltrials.gov) - Aug 4, 2013
P2, N=60, Recruiting, Sponsor: Allergan
- Enrollment change: Erectile Dysfunction Study (clinicaltrials.gov) - Jul 30, 2013
P=N/A, N=64, Completed, Sponsor: Duke University
N=30 --> 16 N=50 --> 64
- Trial completion: Erectile Dysfunction Study (clinicaltrials.gov) - Jul 30, 2013
P=N/A, N=64, Completed, Sponsor: Duke University
N=50 --> 64 Recruiting --> Completed
- | sildenafil / Generic mfg.
New P4 trial: Early Intervention for Erectile Dysfunction After Laparoscopic Resection for Rectal Cancer (clinicaltrials.gov) - Jul 29, 2013
P4, N=90, Recruiting, Sponsor: Nanfang Hospital of Southern Medical University
- |||||||||| Zydena (udenafil) / Mezzion
New P3 trial: Safety Study of Once-a-Day Dosing of Udenafil to Treat Erectile Dysfunction (clinicaltrials.gov) - Jul 15, 2013
P3, N=302, Completed, Sponsor: Dong-A Pharmaceutical Co., Ltd.
- ||| Stendra (avanafil) / Vivus, Menarini, Endo
Enrollment change: Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction (clinicaltrials.gov) - Jul 11, 2013
P4, N=440, Completed, Sponsor: VIVUS, Inc.
Recruiting --> Completed N=300 --> 440
- | Trial completion: Transcutaneous Mechanical Nerve Stimulation (TMNS) by Vibration in the Preservation and Restoration of Urinary Continence and Erectile Function and in the Treatment of Erectile Dysfunction and Urinary Incontinence in Conjunction With Nerve Sparing Radical Prostatectomy (clinicaltrials.gov) - May 22, 2013
P3, N=68, Completed, Sponsor: Copenhagen University Hospital at Herlev
N=300 --> 440 Active, not recruiting --> Completed
- Botox (onabotulinumtoxin A) / GSK, AbbVie
Clinical: VginsmsBOTOX: Injection of Botox in the Perineal Muscles in Resistant Cases of Vaginal Spasm (clinicaltrials.gov) - May 20, 2013
P=N/A, N=20, Recruiting, Sponsor: Abdel-Maguid Ramzy
- |||| Stendra (avanafil) / Vivus, Menarini, Endo
Trial completion: Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction (clinicaltrials.gov) - May 13, 2013
P4, N=440, Completed, Sponsor: VIVUS, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy (clinicaltrials.gov) - May 13, 2013
P0, N=12, Completed, Sponsor: Creighton University
Active, not recruiting --> Completed Recruiting --> Completed
- ||| tadalafil / Generic mfg.
Enrollment closed: Safety and Efficacy of YHD1023 in Erectile Dysfunction (clinicaltrials.gov) - May 12, 2013
P2, N=104, Active, not recruiting, Sponsor: Yuhan Corporation
Recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment change: TERMSINFAT: Testosterone Replacement in Metabolic Syndrome and Inflammation (clinicaltrials.gov) - May 4, 2013
P4, N=70, Recruiting, Sponsor: University of Roma La Sapienza
Recruiting --> Active, not recruiting N=45 --> 70
- Enrollment open: TERMSINFAT: Testosterone Replacement in Metabolic Syndrome and Inflammation (clinicaltrials.gov) - May 4, 2013
P4, N=70, Recruiting, Sponsor: University of Roma La Sapienza
N=45 --> 70 Completed --> Recruiting
- ||||||| Trial completion: Phase III Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction and Hypertension (clinicaltrials.gov) - Apr 15, 2013
P3, N=109, Completed, Sponsor: SK Chemicals Co.,Ltd.
Completed --> Recruiting Recruiting --> Completed
- ||||||| Trial completion: Study to Assess the Efficacy and Safety of SK3530 on Erectile Dysfunction in Patients With Diabetes Mellitus (clinicaltrials.gov) - Apr 15, 2013
P3, N=112, Completed, Sponsor: SK Chemicals Co.,Ltd.
Recruiting --> Completed Recruiting --> Completed
- | Trial completion: Phase 1 Study of SK3530 to Investigate of the Effect of Food (clinicaltrials.gov) - Apr 15, 2013
P1, N=15, Completed, Sponsor: SK Chemicals Co.,Ltd.
Recruiting --> Completed Active, not recruiting --> Completed
- ||||||| alfuzosin hydrochloride / Generic mfg.
Trial completion: An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms (clinicaltrials.gov) - Apr 11, 2013
P3, N=55, Completed, Sponsor: Chesapeake Urology Research Associates
Active, not recruiting --> Completed Recruiting --> Completed
- Vitaros (alprostadil + novel excipient) / Seelos Therap
New P2 trial: Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction (clinicaltrials.gov) - Mar 11, 2013
P2, N=16, Terminated, Sponsor: Warner Chilcott
- | New P4 trial: A Study to Evaluate the Safety and Effectiveness of Mirodenafil in Korean Patients With Erectile Dysfunction (clinicaltrials.gov) - Feb 27, 2013
P4, N=379, Terminated, Sponsor: Janssen Korea, Ltd., Korea
- Enrollment change, Surgery: Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer (clinicaltrials.gov) - Feb 20, 2013
P=N/A, N=112, Completed, Sponsor: East Carolina University
Recruiting --> Completed N=378 --> 112
- Trial completion, Surgery: Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer (clinicaltrials.gov) - Feb 20, 2013
P=N/A, N=112, Completed, Sponsor: East Carolina University
N=378 --> 112 Recruiting --> Completed
- ||| vardenafil / Generic mfg.
Trial completion: REVITALISE: Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice (clinicaltrials.gov) - Feb 18, 2013
P=N/A, N=2289, Completed, Sponsor: Bayer
Recruiting --> Completed Recruiting --> Completed
- Vitaros (alprostadil + novel excipient) / Seelos Therap
New P4 trial: Efficacy, Safety and Satisfaction of VITAROS (Transdermal Topical Alprostadil) in Men With Erectile Dysfunction (clinicaltrials.gov) - Jan 24, 2013
P4, N=0, Withdrawn, Sponsor: Lawson Health Research Institute
- sildenafil / Generic mfg.
Enrollment change: Use of Sildenafil (Viagra) in Diabetic Men With Erectile Dysfunction: the Impact on Blood Vessels (clinicaltrials.gov) - Jan 23, 2013
P4, N=24, Completed, Sponsor: Lawson Health Research Institute
Recruiting --> Completed N=66 --> 24
- sildenafil / Generic mfg.
Trial completion: Use of Sildenafil (Viagra) in Diabetic Men With Erectile Dysfunction: the Impact on Blood Vessels (clinicaltrials.gov) - Jan 23, 2013
P4, N=24, Completed, Sponsor: Lawson Health Research Institute
N=66 --> 24 Recruiting --> Completed
- |||||||||| Zydena (udenafil) / Mezzion
New P3 trial: Efficacy and Safety Study of Udenafil to Treat Erectile Dysfunction (clinicaltrials.gov) - Jan 22, 2013
P3, N=349, Completed, Sponsor: Dong-A Pharmaceutical Co., Ltd.